192 related articles for article (PubMed ID: 33328332)
1. Plasma exosomal
Zhang C; Zhu Z; Gao J; Yang L; Dang E; Fang H; Shao S; Zhang S; Xiao C; Yuan X; Li W; Abe R; Qiao H; Wang G; Fu M
Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328332
[TBL] [Abstract][Full Text] [Related]
2. Exosomal microRNAs from PBMCs stimulated with culprit drugs enhanced keratinocyte cell death in Stevens-Johnson syndrome/toxic epidermal necrolysis.
Suthumchai N; Buranapraditkun S; Thantiworasit P; Rerknimitr P; Wongpiyabovorn J; Khanaraksombat S; Reantragoon R; Klaewsongkram J
J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1375-1384. PubMed ID: 36840393
[TBL] [Abstract][Full Text] [Related]
3. Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage.
Ueta M; Nishigaki H; Sotozono C; Yokoi N; Mizushima K; Naito Y; Kinoshita S
Sci Rep; 2020 Oct; 10(1):17239. PubMed ID: 33057072
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions.
Ichihara A; Wang Z; Jinnin M; Izuno Y; Shimozono N; Yamane K; Fujisawa A; Moriya C; Fukushima S; Inoue Y; Ihn H
J Allergy Clin Immunol; 2014 Apr; 133(4):1065-74. PubMed ID: 24184144
[TBL] [Abstract][Full Text] [Related]
6. An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions.
Saito N; Qiao H; Yanagi T; Shinkuma S; Nishimura K; Suto A; Fujita Y; Suzuki S; Nomura T; Nakamura H; Nagao K; Obuse C; Shimizu H; Abe R
Sci Transl Med; 2014 Jul; 6(245):245ra95. PubMed ID: 25031270
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H
J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role?
Mawson AR; Eriator I; Karre S
Med Sci Monit; 2015 Jan; 21():133-43. PubMed ID: 25579087
[TBL] [Abstract][Full Text] [Related]
9. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
[TBL] [Abstract][Full Text] [Related]
10. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI
Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
[TBL] [Abstract][Full Text] [Related]
11. MiR-20a-3p regulates TGF-β1/Survivin pathway to affect keratinocytes proliferation and apoptosis by targeting SFMBT1 in vitro.
Li R; Qiao M; Zhao X; Yan J; Wang X; Sun Q
Cell Signal; 2018 Sep; 49():95-104. PubMed ID: 29886071
[TBL] [Abstract][Full Text] [Related]
12. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
[TBL] [Abstract][Full Text] [Related]
13. MiR-744-3p regulates keratinocyte proliferation and differentiation via targeting KLLN in psoriasis.
Wang C; Zong J; Li Y; Wang X; Du W; Li L
Exp Dermatol; 2019 Mar; 28(3):283-291. PubMed ID: 30664260
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis.
Paul C; Wolkenstein P; Adle H; Wechsler J; Garchon HJ; Revuz J; Roujeau JC
Br J Dermatol; 1996 Apr; 134(4):710-4. PubMed ID: 8733377
[TBL] [Abstract][Full Text] [Related]
15. Expression of prostaglandin E
Mieno H; Ueta M; Yamada K; Yamanaka Y; Nakayama T; Watanabe A; Kinoshita S; Sotozono C
Br J Ophthalmol; 2020 Jul; 104(7):1022-1027. PubMed ID: 31000507
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNA derived from keratinocytes regulates pigmentation in melanocytes.
Liu Y; Xue L; Gao H; Chang L; Yu X; Zhu Z; He X; Geng J; Dong Y; Li H; Zhang L; Wang H
J Dermatol Sci; 2019 Mar; 93(3):159-167. PubMed ID: 30904353
[TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
Abe R
J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
[TBL] [Abstract][Full Text] [Related]
19. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
French LE; Trent JT; Kerdel FA
Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-124 up-regulation as a disease marker of toxic epidermal necrolysis.
Sato S; Ichihara A; Jinnin M; Izuno Y; Fukushima S; Ihn H
Eur J Dermatol; 2015; 25(5):457-62. PubMed ID: 26394757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
